Vireo Growth New (VREOD) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 3 19 sessions, June 5, 2026 to July 2, 2026
- Largest daily move
- +6.5% close of June 8, 2026
Company Description
Vireo Growth New (OTC: VREOD) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector.
VREOD declined 0.5% in the week to July 2, 2026. The last closing price was $9.95.
For FY2025, Vireo Growth New reported revenue of $268.8M with net income of -$68.1M and diluted earnings per share of -$0.09. The company operates at a net profit margin of -25.3%.
This page collects what Stock Titan holds for VREOD, including price data, latest news, SEC filings, financial highlights, upcoming events, and short interest trends.
Stock Performance
Vireo Growth New (VREOD) closed at $9.95 on July 2, 2026. In the week to July 2, 2026, the price lost 0.5%.
VREOD Metrics & Rankings
Price returns through July 2, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Vireo Growth New has 10 recent news articles, with the latest published 4 days ago. Key topics include earnings date, acquisition, buybacks, earnings. View all VREOD news →
SEC Filings
Vireo Growth New has filed 2 recent SEC filings, including 1 Form 8-K/A, 1 Form 8-K. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all VREOD SEC filings →
Financial Highlights
Vireo Growth New generated $268.8M in revenue in FY2025, retaining a 47.3% gross margin, operating income reached -$1.0M (-0.4% operating margin), and net income was -$68.1M, reflecting a -25.3% net profit margin. Diluted earnings per share stood at -$0.09. The company generated $3.7M in operating cash flow. The current ratio was 1.59, measuring current assets divided by current liabilities.
Upcoming Events
VREO share issuance
Vireo Growth New has 1 upcoming scheduled event. The next event, "VREO share issuance", is scheduled for July 17, 2028 (in 619 days). It is a financing or capital event, such as a dividend or a debt maturity. Investors can track these dates to stay informed about potential catalysts that may affect the VREOD stock price.
Short Interest History
Short interest in Vireo Growth New (VREOD) currently stands at 2 shares, down 97.8% from the previous reporting period. Since June 2026, short interest has decreased by 97.8%.
Days to Cover History
Days to cover for Vireo Growth New (VREOD) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
VREOD Company Profile & Sector Positioning
Vireo Growth New (VREOD) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing VREOD often look at related companies in the same sector, including Merck KGaA (MKGAF), Merck KGaA (MKKGY), Takeda Pharm Co Ltd (TKPHF), Galderma Group AG (GALDY), and Galderma Group AG (GDERF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate VREOD's relative position within its industry.